NEU 1.20% $20.22 neuren pharmaceuticals limited

I agree it continues to de-risk, but I'm not really surprised by...

  1. 138 Posts.
    I agree it continues to de-risk, but I'm not really surprised by the selling to be honest. Many short-term holders would have only stayed if results were excellent, which could potentially result in an imminent deal from pharma. With good results released today, I think the wait / negotiations will be longer. We may even have to wait for Phase III, we don't truly know.

    It's pure opportunity cost IMO for many traders. It didn't look like moving today like they hoped and figure more money to be made elsewhere in a shorter time frame. May be short-sighted, but not surprising really.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.22
Change
0.240(1.20%)
Mkt cap ! $2.584B
Open High Low Value Volume
$20.11 $20.34 $19.63 $8.874M 441.3K

Buyers (Bids)

No. Vol. Price($)
1 1010 $20.22
 

Sellers (Offers)

Price($) Vol. No.
$20.23 1443 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.